Dual 5-alpha reductase inhibition promotes hepatic lipid accumulation in man.

CONCLUSIONS: Dual SRD5A inhibition with Dutasteride is associated with increased intrahepatic lipid accumulation. PMID: 26574953 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26574953?dopt=Abstract

Source: Diabetes Metab - November 17, 2015 Category: Endocrinology Authors: Hazlehurst JM, Oprescu AI, Nikolaou N, Di Guida R, Grinbergs AE, Davies NP, Flintham RB, Armstrong MJ, Taylor AE, Hughes BA, Yu J, Hodson L, Dunn WB, Tomlinson JW Tags: J Clin Endocrinol Metab Source Type: research